Dedicated to delivering high-quality medicines

Our Blansko site plays a crucial role in our API manufacturing capabilities. Due to the integration of API R&D on the site, this plant enables rapid development and launches of new APIs, especially in the High Potent area. Next to this, the site is the Center of Excellence for Analytical Operations. With a wide range of technologies, we also manufacture linker drugs for the growing field of Antibody Drug Conjugates (ADC) as well as and oligonucleotides synthesis capabilities in commercial/advanced development stages. The site has GMP certificates from practically all regions in the world, including FDA and EMA.

Our Santiago site is a robust Drug Product manufacturing facility that enables us to meet the growing global demands in high potent products, and pre-filled syringes. The site also has a strong focus on producing Drug Products for the local market. The site was the first EMA approved South American site.

Our second API manufacturing site is located in San Lorenzo.  The site produces standard as well as high potent APIs for our internal drug product sites. Also this site has GMP approval from most regions in the world, like FDA and EMA.